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To date, there has been no literature reported on the mechanism of 
Typhonium flagelliforme and its effects on leukemia. Hence, the anti-
leukemia effect of Typhonium flagelliforme was investigated in vitro and in 
vivo leukemic model. Extraction and fractionation using organic solvents 
were applied to obtain fractions from T. flagelliforme and subsequently, 
chemical analysis was done using GC-MS. In vitro cytotoxic effects of 
extracts and fractions were tested in several human cancer cell lines 
including leukemia (CEMss cells) using MTT assay. Various microscopy 
techniques were used to study morphological changes occurring during 
treatment. The Annexin V assay, TUNEL assay, cell cycle analysis and DNA 
laddering were employed to detect apoptosis. Colourimetric assays for 
caspase-3 and 9, immunoblot analysis for cytochrome c, BcL-2, PARP, FasL 
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and β-actin were analysed. The in vivo model of leukemia was induced in 
male BALB/c mice using WEHI-3 cells. The DCM extract of the plant tuber 
was used for treatment at various doses. Amongst 8 plant extracts 
investigated, the dichloromethane (DCM) extracts of T. flagelliforme tuber 
demonstrated low and significant anti proliferative effect against both CEMss 
(6.5±0.4 µg/ml) and WEHI-3 cells (24.0±5.2 µg/ml) (p<0.05). Further 
fractionation of the DCM tuber extract resulted into 12 fractions. Seven of 
these 12 fractions showed significant cytotoxicity against CEMss, in which 
the DCM/F7, DCM/F11 and DCM/F12 fractions showed highest anti-cancer 
activities of 3.0, 5.0 and 6.2 µg/ml respectively. Further studies of these 
fractions towards non cancerous Peripheral Blood Lymphocytes (PBL) 
exhibited significant selectivity of DCM/F7 compared to other fractions. 
Phytochemical analysis using GC-MS revealed that the DCM/F7 fraction 
contains linoleic acid (51.20%), n-hexadecanoic acid (17.89%), 9-
hexadecanoic acid (6.99%) and Stigmasta-5,22-dien-3-ol (6.06%). 
Cytological observations exhibited chromatin condensation, cell shrinkage, 
abnormalities of cristae, membrane blebbing, cytoplasmic extrusions and 
formation of apoptotic bodies, further confirmed using AO/PI, SEM and TEM 
analysis. The Annexin V and TUNEL assay revealed apoptotic induction in 
CEMss cells exposed to the DCM/F7 in a time-dependent manner, whilst 
DNA fragmentation of CEMss cells were detected using 1.0% agarose gel 
electrophoresis. The DCM/F7 fraction significantly (p<0.05) stimulated both 
caspases 3 and 9 activities. The immunoblot results revealed that DCM/F7 
caused the release of mitochondrial cytochrome c and cleaved 116 kDa 
PARP into 85 kDa fragments. The Bcl-2 protein was found to decrease 
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during treatment. Meanwhile, FasL did not exhibit up or down regulation on 
treatment. Cell cycle analysis revealed that there is significant (p<0.05) G1 
phase arrest in a time-depended manner. The DCM extract of T. 
flagelliforme tuber in vivo markedly inhibited the proliferation of WEHI-3 in 
male BALB/c mice as evidenced by reduction in the percentage of immature 
monocytes as well as granulocytes, liver weight, spleen weight and 
histopathological profiles of H&E stained spleen tissue. The DCM tuber 
extract of T. flagelliforme significantly decreased the spleen tumor size, 
which had dose-dependent effects. Sections of spleen tissue of the BALB/c 
mice treated with the extract. Treatment at 800 mg/kg dose showed 
evidence of apoptosis in comparison to the control groups. Collectively, 
results presented in this study demonstrate that T. flagelliforme, a local 
herbal medicinal plant in Malaysia inhibited the proliferation of leukemia in 
vitro selectively, leading to the programmed cell death, which was later 
confirmed to lead through mitochondrial pathways. Moreover, in vivo study 
on an orthotopic BALB/c mice model clearly shows that, T. flagelliforme 
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Sehingga hari ini, belum terdapat sorotan literatur yang melaporkan 
mekanisma Typhonium flagelliforme dan kesannya terhadap leukemia. Oleh 
itu, kesan anti-leukemia dari Typhonium flagelliforme dikaji menggunakan 
model leukemia secara in vitro dan in vivo. Kaedah ekstraksi dan fraksinasi 
menggunakan pelarut organik digunakan untuk mendapatkan fraksi dari T. 
flagelliforme dan seterusnya, analisis kimia dijalankan menggunakan kaedah 
GC-MS. Kesan sitotoksik in vitro ekstrak dan pecahannya telah diuji 
terhadap beberapa sel kanser manusia termasuk leukemia (sel CEMss) 
menggunakan asai MTT. Beberapa teknik mikroskopi telah digunakan untuk 
mengkaji perubahan morfologi yang berlaku semasa rawatan. Asai Annexin 
V, Asai TUNEL, analisis kitaran sel dan dan tetangga DNA telah digunakan 
untuk mengesan apoptosis. Asai kalorimetrik bagi caspase-3 dan 9, analisis 
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imunoblot untuk sitokrom c, BcL-2, FasL dan β-actin telah dianalisa. Bagi 
model leukemia secara in vivo tikus jantan BALB/c diaruh menggunakan sel 
WEHI-3. Ekstrak DCM tanaman tuber telah digunakan untuk rawatan dalam 
beberapa dos. Diantara 8 ekstrak tumbuhan yang diuji, ekstrak tuber T. 
flagelliforme yang menggunakan diklorometana (DCM) menunjukkan kesan 
anti proliferasi terhadap kedua-dua sel; CEMss (6.5±0.4 µg/ml) dan WEHI-3 
(24.0±5.2 µg/ml) (p<0.05). Fraksinasi lanjutan ekstrak tuber dengan 
menggunakan DCM telah menghasilkan 12 fraksi. 7 daripada 12 fraksi 
menunjukkan kesan sitotoksik yang signifikan terhadap CEMss, di mana 
fraksi DCM/F7, DCM/F11 dan DCM/F12 menunjukkan aktiviti anti-kanser 
paling tinggi dengan 3.0, 5.0 dan 6.2 µg/ml. Kajian lanjutan terhadap fraksi 
ini adalah pada Limfosit Darah Periferi (PBL) bukan kanser menunjukkan 
kesan pemilihan yang signifikan pada DCM/F7 dibandingkan terhadap fraksi 
lain. Analisis fitokimia menggunakan GC-MS mendedahkan fraksi DCM/F7 
mengandungi asid linoleik (51.20%), asid n-hexadekanoat (17.89%), asid 9-
heksadekanoat (6.99%) dan Stigmasta-5, 22-dien-3-ol (6.06%). Pemerhatian 
sitologi menunjukkan kondensasi kromatin, pengecutan sel, ketidaknormalan 
krista, penggelembungan membran, penonjolan sitoplasma dan 
pembentukan jasad apoptotik, Seterusnya pengesahan adalah 
menggunakan analisis AO/PI, SEM dan TEM. Asai Annexin V dan TUNEL 
menunjukkkan rangsangan apoptotik pada sel CEMss dikesan 
menggunakan 1.0% elektroforesis agarose gel. Fraksi DCM/F7 mendorong 
peningkatan aktiviti caspase 3 dan 9 secara signifikan pada (p<0.05). 
Keputusan imunoblot mendedahkan DCM/F7 menyebabkan pembebasan 
sitokrom c mitokondria dan pemecahan 116kDa PARP kepada 85 kDa 
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fragmen. Protein Bcl-2 didapati berkurang semasa rawatan. Sementara itu, 
FasL tidak menunjukkan peningkatan atau penurunan pngawalaturan 
terhadap rawatan. Analisis kitaran sel mendedahkan terdapat penahanan 
fasa G1 yang signifikan (p<0.05) dalam cara kebergantungan pada masa. 
Kajian ekstrak DCM tuber T. flagelliforme in vivo didapati merencatkan 
proliferasi WEHI-3 pada tikus jantan BALB/c seperti yang dibuktikan dengan 
penurunan dalam peratus monosit yang tidak matang dan juga granulosit, 
berat hati, berat hati, berat limpa dan profil histopatologi bagi H&E tisu limpa 
yang diwarnakan. Ekstrak tuber DCM T. flagelliforme mengurangkan saiz 
limpa dengan signifikan yang mempunyai kesan kebergantungan dos. Tisu 
bahagian limpa tikus jantan BALB/c dirawat dengan ekstrak. Rawatan pada 
dos 800 mg/kg menunjukkan bukti kejadian apoptosis dibandingkan dengan 
kumpulan kawalan. Secara kolektif, keputusan yang dibentangkan dalam 
kajian ini menunjukkan tumbuhan herba ubatan tempatan di Malaysia, T. 
flagelliforme telah menghalang proliferasi leukemia secara in vitro, 
membawa kepada kematian sel yang diprogramkan, yang mana 
kemudiannya disahkan melalui laluan mitokondia. Tambahan lagi, kajian in 
vivo pada model ortotopik T. flagelliforme jelas menunjukkan ekstrak tuber T. 
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